UK Diabetes Care Devices Market Analysis and Forecasts to 2015

Date: August 1, 2009
Pages: 119
Price:
US$ 3,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: U2702558414EN
Leaflet:

Download PDF Leaflet

UK Diabetes Care Devices Market Analysis and Forecasts to 2015
GlobalData’s “UK Diabetes Care Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the UK diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories and provides key analytical insights on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & analysis of a key market within the medical device industry, diabetes care devices market, to 2015.
- Market segmentation of the diabetes care devices market in the United Kingdom (UK) into glucose monitoring and insulin delivery. Glucose monitoring further segmented into blood glucose meters and blood glucose test strips. Insulin delivery further segmented into insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
- Analysis of key diabetes care pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the UK diabetes care devices market.
- Develop a clear knowledge & understanding of the UK diabetes care devices competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the UK diabetes care devices market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

1 TABLE OF CONTENTS


1.1 LIST OF TABLES


1.2 LIST OF FIGURES


2 INTRODUCTION

2.1 What Is This Report About?

3 EXECUTIVE SUMMARY


4 DEFINITIONS OF MARKETS COVERED IN THE REPORT

4.1 Diabetic Care Devices
4.2 Glucose Monitoring Devices
  4.2.1 Blood Glucose Meters
  4.2.2 Blood Glucose Strips
4.3 Insulin Delivery
  4.3.1 Insulin Pens
  4.3.2 Insulin Syringes
  4.3.3 Insulin Pumps
  4.3.4 Traditional Insulin Pump Accessories

5 HEALTHCARE SECTOR REVIEW

5.1 Healthcare Expenditure
5.2 Healthcare Infrastructure
5.3 Healthcare Policy
5.4 UK Healthcare Trade Statistics

6 REGULATION SYSTEM

6.1 Medical Equipment Approval Process
  6.1.1 Classification of Medical Devices
  6.1.2 Conformity Assessment Process
6.2 Medical Device approval fee
6.3 Post Market Surveillance (PMS)

7 PRICING AND REIMBURSEMENT

7.1 Market Pricing
7.2 Government Policies for Reimbursement

8 DISTRIBUTION STRUCTURE


9 DIABETES CARE DEVICES IN UK

9.1 Diabetes Care Devices, UK, Overall Revenue ($ m), 2000-2015
9.2 Diabetes Care Devices, UK, Category Volume (Units), 2000-2015
9.3 Diabetes Care Devices, UK, Key Market Trends
  9.3.1 Increasing Prevalence of Diabetes in UK to Drive the Market
  9.3.2 Aging Population
  9.3.3 High Obesity Prevalence and Sedentary Lifestyles
  9.3.4 Home Diabetes Care Driving Growth
  9.3.5 Remote Monitoring: Increasing Diabetic Compliance
  9.3.6 Increasing Demand for Pain Free Insulin Delivery Devices
  9.3.7 Emergence of Continuous Glucose Monitoring (CGM) to drive Growth in the Market
  9.3.8 Drug Stores to Remain the Major Distribution Channels
  9.3.9 High Cost of Insulin Pumps
9.4 Diabetes Care Devices, UK, Company Share (2007-2008)

10 GLUCOSE MONITORING IN UK

10.1 Glucose Monitoring Overall Revenue (2000-2015)
  10.1.1 Blood Glucose Meters Overall Revenue (2000-2015)
10.2 Glucose Monitoring Overall Volume (2000-2015)
  10.2.1 Blood Glucose Meters Overall Volume (2000-2015)
10.3 Glucose Monitoring Average Price (2000-2015)
10.4 Glucose Monitoring Market Dynamics
  10.4.1 Market Drivers
  10.4.2 Market Restraints
10.5 Glucose Monitoring Distribution Share (2007-2008)
10.6 Glucose Monitoring, UK, Company Share (2007-2008)

11 INSULIN DELIVERY IN UK

11.1 Insulin Delivery Overall Revenue (2000-2015)
  11.1.1 Insulin Pens Overall Revenue (2000-2015)
11.2 Insulin Delivery Overall Volume (2000-2015)
  11.2.1 Insulin Pens Overall Volume (2000-2015)
11.3 Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015
11.4 Insulin Delivery Average Price (2000-2015)
11.5 Insulin Delivery Market Dynamics
11.6 Insulin Delivery Distribution Share (2007-2008)
11.7 Insulin Delivery, UK, Company Share (2007-2008)

12 OVERVIEW OF KEY COMPANIES IN UK DIABETES CARE DEVICES MARKET

12.1 F. Hoffmann-La Roche Ltd.
  12.1.1 Company Overview
  12.1.2 F. Hoffmann-La Roche Ltd Pipeline Products
12.2 LifeScan, Inc.
  12.2.1 Company Overview
  12.2.2 LifeScan, Inc. Pipeline Products
12.3 Bayer HealthCare AG
  12.3.1 Company Overview
  12.3.2 Bayer HealthCare AG Pipeline Products
12.4 Abbott Laboratories
  12.4.1 Company Overview
  12.4.2 Abbott Laboratories Pipeline Products
12.5 Novo Nordisk A/S
  12.5.1 Company Overview
  12.5.2 Novo Nordisk A/S Pipeline Products
12.6 Becton, Dickinson and Company
  12.6.1 Company Overview
12.7 Eli Lilly and Company
  12.7.1 Company Overview
  12.7.2 Eli Lilly and Company Pipeline Products
12.8 Medtronic, Inc.
  12.8.1 Company Overview
  12.8.2 Medtronic, Inc. Pipeline Products
12.9 ARKRAY, Inc.
  12.9.1 Company Overview
12.10 Terumo Corporation
  12.10.1 Company Overview
12.11 Animas Corporation
  12.11.1 Company Overview
12.12 Sanofi-Aventis
  12.12.1 Company Overview
12.13 Smiths Medical
  12.13.1 Company Overview

13 RECENT DEVELOPMENTS

13.1 Strategy and Business Planning
  13.1.1 Mar 25, 2009: Smiths Medical Intents To Stop Selling Deltec Cozmo Insulin Pumps
13.2 Government and Public Interest
  13.2.1 Apr 29, 2009: Warning About Failing Insulin Infusion Pump, UK
13.3 Product News
  13.3.1 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring System Helps To Improve Patient Care
  13.3.2 Feb 03, 2009: Accu-Chek Aviva Nano Designed To Motivate Patients For Self-Management Of Diabetes

14 APPENDIX

14.1 GlobalData Research Methodology
14.2 Secondary Research
14.3 Primary Research
14.4 Models
14.5 Forecasts
14.6 Expert Panel Validation
14.7 Currency Conversion
14.8 Contact Us
14.9 Disclaimer

1.1 LIST OF TABLES

Table 1: Total Healthcare Expenditure ($bn), UK, 2000 – 2007
Table 2: Number of Doctor by Specialty in UK, 2003 - 2007
Table 3: UK Healthcare Trade Statistics, 2001-2006
Table 4: Medical Device Approval Fee in UK, 2006
Table 5: Diabetes Care Devices, UK, Overall Revenue ($ m), Historic, 2000-2008
Table 6: Diabetes Care Devices, UK, Overall Revenue ($ m), Forecast, 2008 – 2015
Table 7: Diabetes Care Devices, UK, Category Volume (Units), Historic, 2000-2008
Table 8: Diabetes Care Devices, UK, Category Volume (Units), Forecast, 2008-2015
Table 9: Diabetes Prevalence, UK, 2008
Table 10: Diabetes Prevalence by Region, UK, 2008
Table 11: Diabetes Care Devices, UK, Company Share by Revenue ($ m), 2007-2008
Table 12: Glucose Monitoring, UK, Revenue ($ m) by Segment, Historic, 2000-2008
Table 13: Glucose Monitoring, UK, Revenue ($ m) by Segment, Forecast, 2008-2015
Table 14: Blood Glucose Meters, UK, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
Table 15: Blood Glucose Meters, UK, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
Table 16: Glucose Monitoring, UK, Volume (Units) by Segment, Historic, 2000-2008
Table 17: Glucose Monitoring, UK, Volume (Units) by Segment, Forecast, 2008-2015
Table 18: Blood Glucose Meters, UK, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 19: Blood Glucose Meters, UK, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 20: Glucose Monitoring, UK, Average Price ($), Historic, 2000-2008
Table 21: Glucose Monitoring, UK, Average Price ($), Forecast, 2008-2015
Table 22: Glucose Monitoring, UK, Distribution Share by Revenue ($ m), 2007-2008
Table 23: Glucose Monitoring, UK, Company Share by Revenue ($ m), 2007-2008
Table 24: Insulin Delivery, UK, Revenue ($ m) by Segment, Historic, 2000-2008
Table 25: Insulin Delivery, UK, Revenue ($ m) by Segment, Forecast, 2008-2015
Table 26: Insulin Pens, UK, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
Table 27: Insulin Pens, UK, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
Table 28: Insulin Delivery, UK, Volume (Units) by Segment, Historic, 2000-2008
Table 29: Insulin Delivery, UK, Volume (Units) by Segment, Forecast, 2008-2015
Table 30: Insulin Pens, UK, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 31: Insulin Pens, UK, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 32: Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015
Table 33: Insulin Delivery, UK, Average Price ($), Historic, 2000-2008
Table 34: Insulin Delivery, UK, Average Price ($), Forecast, 2008-2015
Table 35: Insulin Delivery, UK, Distribution Share by Revenue ($ m), 2007-2008
Table 36: Insulin Delivery, UK, Company Share by Revenue ($ m), 2007-2008
Table 37: F. Hoffmann-La Roche Ltd Pipeline Product by Equipment Type
Table 38: F. Hoffmann-La Roche Ltd Pipeline Product by Development Stage
Table 39: F. Hoffmann-La Roche Ltd Pipeline Product by Therapy Area
Table 40: LifeScan, Inc. Pipeline Product by Equipment Type
Table 41: LifeScan, Inc. Pipeline Product by Therapy Area
Table 42: LifeScan, Inc. Pipeline Products by Clinical Trials
Table 43: Bayer HealthCare AG Pipeline Products by Equipment Type
Table 44: Bayer HealthCare AG Pipeline Products by Development Stage
Table 45: Bayer HealthCare AG Pipeline Products by Therapy Area
Table 46: Abbott Laboratories Pipeline Products by Equipment Type
Table 47: Abbott Laboratories Pipeline Products by Development Stage
Table 48: Abbott Laboratories Pipeline Products by Therapy Area
Table 49: Novo Nordisk A/S Pipeline Products by Equipment Type
Table 50: Novo Nordisk A/S Pipeline Products By Development Stage
Table 51: Novo Nordisk A/S Pipeline Products By Therapy Area
Table 52: Novo Nordisk A/S Pipeline Products By Clinical Trials
Table 53: Eli Lilly and Company Pipeline Products by Equipment Type
Table 54: Eli Lilly and Company Pipeline Products by Development Stage
Table 55: Eli Lilly and Company Pipeline Products by Therapy Area
Table 56: Medtronic, Inc. Pipeline Products by Equipment Type
Table 57: Medtronic, Inc. Pipeline Products By Development Stage
Table 58: Medtronic, Inc. Pipeline Products By Therapy Area
Table 59: Medtronic, Inc. Pipeline Products By Clinical Trials
Table 60: USD to Local Currency, Average Exchange Rate 2008

1.2 LIST OF FIGURES

Figure 1: Total Healthcare Expenditure ($bn), UK, 2000 – 2007
Figure 2: Government and Private Healthcare Expenditure (%), UK, 2007
Figure 3: Flowchart for Classification of Non-invasive Devices in UK, 2007
Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
Figure 7: Flowchart for Classification of Invasive Devices in UK, 2007
Figure 8: Flowchart for Classification of Active Devices in UK, 2007
Figure 9: Flowchart for Classification of Active Devices in UK, 2007
Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
Figure 11: Conformity Assessment of Class-I Medical Devices in UK, 2007
Figure 12: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
Figure 13: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
Figure 14: Conformity Assessment of Class-III Medical Devices in UK, 2007
Figure 15: Diabetes Care Devices, UK, Overall Revenue ($ m), Historic, 2000-2008
Figure 16: Diabetes Care Devices, UK, Overall Revenue ($ m), Forecast, 2008 – 2015
Figure 17: Diabetes Care Devices, UK, Category Volume (Units), Historic, 2000-2008
Figure 18: Diabetes Care Devices, UK, Category Volume (Units), Forecast, 2008-2015
Figure 19: Diabetes Prevalence in UK, 1996-2025
Figure 20: Diabetes Care Devices, UK, Company Share (%), 2008
Figure 21: Blood Glucose Meters, UK, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
Figure 22: Blood Glucose Meters, UK, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
Figure 23: Glucose Monitoring, UK, Company Share (%), 2008
Figure 24: Insulin Delivery, UK, Revenue ($ m) by Segment, Historic, 2000-2008
Figure 25: Insulin Delivery, UK, Revenue ($ m) by Segment, Forecast, 2008-2015
Figure 26: Insulin Pens, UK, Revenue ($ m) by Sub-Segment, Historic, 2000-2008
Figure 27: Insulin Pens, UK, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015
Figure 28: Insulin Pens, UK, Volume (Units) by Sub-Segment, Historic, 2000-2008
Figure 29: Insulin Pens, UK, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Figure 30: Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015
Figure 31: Insulin Delivery, UK, Company Share (%), 2008
Figure 32: GlobalData Methodology
F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Bayer HealthCare AG
Abbott Laboratories
Novo Nordisk A/S
Becton, Dickinson and Company
Eli Lilly and Company
Medtronic, Inc.
ARKRAY, Inc.
Terumo Corporation
Animas Corporation
Sanofi-Aventis
Smiths Medical

Ask Your Question

UK Diabetes Care Devices Market Analysis and Forecasts to 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: